InvestorsHub Logo
Followers 36
Posts 5225
Boards Moderated 4
Alias Born 04/05/2017

Re: GetSeriousOK post# 33259

Thursday, 10/31/2024 10:49:07 AM

Thursday, October 31, 2024 10:49:07 AM

Post# of 33351
ENDV misses all timelines. Is best not to have any expectations and continue to be disappointed. The Abrams orthopedic study has been postponed and delayed multiple times. 

A study, not sponsored by ENDV, but using the Sofpulse by Christine Rhode, produced no noticeable advantages of using Sofpulse after mastectomy procedure.

Ilfeld's study might be the last saving spark ENDV needs to stay alive.